Population
Cancer patients at risk for or experiencing venous thromboembolism
Design
Review
Authors
Loading...
May warrant tailored anticoagulation strategies in cancer-associated VTE; leaves open optimal regimens balancing recurrence and bleeding risks.
Cancer patients face a high risk of venous thromboembolism and present unique treatment challenges due to elevated risks of both recurrence and bleeding.
Hart et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: